In a phase 3, open-label safety extension study, researchers evaluated the safety of oral edaravone in patients with amyotrophic lateral sclerosis over 96 weeks.

Presenting at AAN 2025, researchers evaluated gender, racial, and ethnic representation trends among US academic neurology faculty between 1972 and 2021.

In a cross-sectional study, researchers assessed the relationship between neurophobia and the probability of specializing in neurology as a future career path among Hispanic medical students.

In a retrospective cohort study, researchers assessed the effectiveness of prophylactic zonisamide for the prevention of migraine attacks in pediatric patients.

In a large-scale prospective design study, researchers analyzed associations between accelerometer-measured physical activity and sedentary behavior with neuropsychiatric diseases.

In a phase 3, randomized, double-blind, placebo-controlled trial, researchers assessed the efficacy and safety of AXS-12 (reboxetine) in patients with narcolepsy.

Researchers sought to assess temporal trends in aspiration pneumonia and Alzheimer disease-related mortality in older adults in the United States by gender, race, urbanization, place of death, region, and state.

Researchers sought to assess mortality trends associated with hypertension-related vascular dementia across various demographics in the United States.

Researchers sought to evaluate the efficacy, safety, and tolerability of fremanezumab in children and adolescents with episodic migraine.

Researchers assessed Parkinson’s Disease Sleep Scale-2 (PDSS-2) scores in patients with PD who converted to treatment with carbidopa-levodopa in the RISE-PD trial.